The results of the treatment of patients with advanced hepatocellular carcinoma in Sverdlovsk region

by V V Petkau, A A Tarkhanov, E A Kiselev
Published 2017-01-01

Criteria for Responses of Renal Cancer Metastases to Targeted and Immunotherapy

by V. S. Blinov, A. S. Blinova, V. V. Petkau, S. M. Demidov
Published 2020-09-01

The influence of accessibility of anticancer drug therapy on the target indicators of the oncological service

by V. V. Petkau, А. А. Karimova, S. А. Efremov, Е. А. Gruzdeva
Published 2021-06-01

Oncological care for the patients with hepatocellular carcinoma in COVID-19 pandemic

by V. V. Petkau, V. V. Breder, E. N. Bessonova, K. K. Laktionov, I. S. Stilidi
Published 2020-07-01

Interdisciplinary model of patient care for groups at risk for malignant tumors of the skin

by M. A. Ufimtseva, A. S. Shubina, V. V. Petkau, N. L. Struin, D. E. Emel'janov, E. A. Levchenko
Published 2019-10-01

Clinical cases of treatment of patients with advanced hepatocellular carcinoma

by V V Petkau, O A Gladkov, P N Filatov, M V Raigorodskii, A A Tarkhanov, A V Klimushkin, L Yu Nikitina
Published 2018-03-01

Toxicity and efficacy of biosimilar bevacizumab in the second-line therapy for metastatic colon cancer in routine clinical practice: results of an independent observational study

by M.   Yu. Fedyanin, F.   V. Moiseenko, M.   A. Lyadova, V.  N.  Vorobyeva, V.  V.  Petkau, A.  V.  Fateeva, E.  S.  Kuzmina, O.  Yu.  Novikova, V.   A. Chubenko, N.  Kh.  Abduloeva, A.  A.  Kudryavtsev, E.   O. Ignatova, R.   R. Shakirov, O.  A.  Pardabekova, L.  V.  Kindyalova, S.  P.  Pelikh, O.   A. Gladkov, S.  A.  Tjulandin, A.  A.  Tryakin
Published 2021-06-01